Albireo Pharma (ALBO) Stock Has Been Surging After NDA Acceptance
Shan Zee
February 2, 2021
Shares of a clinical-stage rare liver disease corporation that creates new bile acid modulators, Albireo Pharma, Inc. (ALBO) surged by +6.49% to close the trading